212 related articles for article (PubMed ID: 27708228)
21. The Kaposi's sarcoma-associated herpesvirus (KSHV) non-structural membrane protein K15 is required for viral lytic replication and may represent a therapeutic target.
Abere B; Mamo TM; Hartmann S; Samarina N; Hage E; Rückert J; Hotop SK; Büsche G; Schulz TF
PLoS Pathog; 2017 Sep; 13(9):e1006639. PubMed ID: 28938025
[TBL] [Abstract][Full Text] [Related]
22. Cell signaling pathways engaged by KSHV.
Järviluoma A; Ojala PM
Biochim Biophys Acta; 2006 Aug; 1766(1):140-58. PubMed ID: 16828973
[TBL] [Abstract][Full Text] [Related]
23. Global metabolic profiling of infection by an oncogenic virus: KSHV induces and requires lipogenesis for survival of latent infection.
Delgado T; Sanchez EL; Camarda R; Lagunoff M
PLoS Pathog; 2012; 8(8):e1002866. PubMed ID: 22916018
[TBL] [Abstract][Full Text] [Related]
24. Human Mesenchymal Stem Cells of Diverse Origins Support Persistent Infection with Kaposi's Sarcoma-Associated Herpesvirus and Manifest Distinct Angiogenic, Invasive, and Transforming Phenotypes.
Lee MS; Yuan H; Jeon H; Zhu Y; Yoo S; Shi S; Krueger B; Renne R; Lu C; Jung JU; Gao SJ
mBio; 2016 Jan; 7(1):e02109-15. PubMed ID: 26814175
[TBL] [Abstract][Full Text] [Related]
25. Synergy between Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6 and HIV-1 Nef protein in promotion of angiogenesis and oncogenesis: role of the AKT signaling pathway.
Zhu X; Guo Y; Yao S; Yan Q; Xue M; Hao T; Zhou F; Zhu J; Qin D; Lu C
Oncogene; 2014 Apr; 33(15):1986-96. PubMed ID: 23604117
[TBL] [Abstract][Full Text] [Related]
26. In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma.
Mutlu AD; Cavallin LE; Vincent L; Chiozzini C; Eroles P; Duran EM; Asgari Z; Hooper AT; La Perle KM; Hilsher C; Gao SJ; Dittmer DP; Rafii S; Mesri EA
Cancer Cell; 2007 Mar; 11(3):245-58. PubMed ID: 17349582
[TBL] [Abstract][Full Text] [Related]
27. SIRT1 controls cell proliferation by regulating contact inhibition.
Cho EH; Dai Y
Biochem Biophys Res Commun; 2016 Sep; 478(2):868-72. PubMed ID: 27514448
[TBL] [Abstract][Full Text] [Related]
28. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus.
Flore O; Rafii S; Ely S; O'Leary JJ; Hyjek EM; Cesarman E
Nature; 1998 Aug; 394(6693):588-92. PubMed ID: 9707121
[TBL] [Abstract][Full Text] [Related]
29. Reactivation of Kaposi's sarcoma-associated herpesvirus by natural products from Kaposi's sarcoma endemic regions.
Whitby D; Marshall VA; Bagni RK; Miley WJ; McCloud TG; Hines-Boykin R; Goedert JJ; Conde BA; Nagashima K; Mikovits J; Dittmer DP; Newman DJ
Int J Cancer; 2007 Jan; 120(2):321-8. PubMed ID: 17066452
[TBL] [Abstract][Full Text] [Related]
30. Degradation of p27(Kip) cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex.
Ellis M; Chew YP; Fallis L; Freddersdorf S; Boshoff C; Weiss RA; Lu X; Mittnacht S
EMBO J; 1999 Feb; 18(3):644-53. PubMed ID: 9927424
[TBL] [Abstract][Full Text] [Related]
31. A functional genomics approach to Kaposi's sarcoma.
Moses AV; Jarvis MA; Raggo C; Bell YC; Ruhl R; Luukkonen BG; Griffith DJ; Wait CL; Druker BJ; Heinrich MC; Nelson JA; Fruh K
Ann N Y Acad Sci; 2002 Dec; 975():180-91. PubMed ID: 12538164
[TBL] [Abstract][Full Text] [Related]
32. Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: role of JAK/STAT signaling.
Zeng Y; Zhang X; Huang Z; Cheng L; Yao S; Qin D; Chen X; Tang Q; Lv Z; Zhang L; Lu C
J Virol; 2007 Mar; 81(5):2401-17. PubMed ID: 17151125
[TBL] [Abstract][Full Text] [Related]
33. Novel cellular genes essential for transformation of endothelial cells by Kaposi's sarcoma-associated herpesvirus.
Raggo C; Ruhl R; McAllister S; Koon H; Dezube BJ; Früh K; Moses AV
Cancer Res; 2005 Jun; 65(12):5084-95. PubMed ID: 15958552
[TBL] [Abstract][Full Text] [Related]
34. Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease.
Abe Y; Matsubara D; Gatanaga H; Oka S; Kimura S; Sasao Y; Saitoh K; Fujii T; Sato Y; Sata T; Katano H
Pathol Int; 2006 Oct; 56(10):617-24. PubMed ID: 16984619
[TBL] [Abstract][Full Text] [Related]
35. Genipin Enhances Kaposi's Sarcoma-Associated Herpesvirus Genome Maintenance.
Cho M; Jung SW; Lee S; Son K; Park GH; Jung JW; Shin YS; Seo T; Hyosun Cho ; Kang H
PLoS One; 2016; 11(10):e0163693. PubMed ID: 27736870
[TBL] [Abstract][Full Text] [Related]
36. STAT3 Regulates Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus.
King CA; Li X; Barbachano-Guerrero A; Bhaduri-McIntosh S
J Virol; 2015 Nov; 89(22):11347-55. PubMed ID: 26339061
[TBL] [Abstract][Full Text] [Related]
37. Propranolol Decreases Proliferation of Endothelial Cells Transformed by Kaposi's Sarcoma-Associated Herpesvirus and Induces Lytic Viral Gene Expression.
McAllister SC; Hanson RS; Manion RD
J Virol; 2015 Nov; 89(21):11144-9. PubMed ID: 26269192
[TBL] [Abstract][Full Text] [Related]
38. Cannabinoid modulation of Kaposi's sarcoma-associated herpesvirus infection and transformation.
Zhang X; Wang JF; Kunos G; Groopman JE
Cancer Res; 2007 Aug; 67(15):7230-7. PubMed ID: 17671191
[TBL] [Abstract][Full Text] [Related]
39. Persistent activation of STAT3 by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells.
Punjabi AS; Carroll PA; Chen L; Lagunoff M
J Virol; 2007 Mar; 81(5):2449-58. PubMed ID: 17151100
[TBL] [Abstract][Full Text] [Related]
40. Unveiling the role of KSHV-infected human mesenchymal stem cells in Kaposi's sarcoma initiation.
Lacunza E; Ahuja A; Coso OA; Abba M; Ramos JC; Cesarman E; Mesri EA; Naipauer J
J Med Virol; 2024 May; 96(5):e29684. PubMed ID: 38773828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]